search
Back to results

Evaluation of the Impact of the AVanCer Program Provided by the ARRPAC Day Center (Eval-ARRPAC)

Primary Purpose

Stroke, Brain Injury, Rehabilitation

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Evaluation of program "AVanCer"
Sponsored by
Hospices Civils de Lyon
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Stroke focused on measuring Stroke, Brain injury, Rehabilitation, Autonomy, Caregivers

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: For patients : Male or female of legal age Patient who has been selected to start the AVanCer program at the ARRPAC center Patient who has agreed to participate in the PATIENT assessment component and has signed the consent form Patient able to speak and understand French both orally and in writing For caregivers : Male or female of legal age Person who has agreed to participate in the CAREGIVING assessment component and has signed the consent form Person able to speak and understand French both orally and in writing Population of the qualitative study : Voluntary patients and caregivers who participated in the quantitative part (follow-up by questionnaires) Partner professionals: a sample of 10 representatives of ARRPAC partners who referred people for support during the first 12 months, from the following structures: public Medicine, Surgery, Obstetric health institution, private Medicine, Surgery, Obstetric health institution, public Follow-up and Rehabilitation Care institution, private Follow-up and Rehabilitation Care institution, medico-social institution, town professionals and user associations. ARRPAC professionals: the 14 ARRPAC professionals involved in the day care centre will be interviewed in a semi-structured manner Exclusion Criteria: Pregnant women, parturient or breastfeeding mothers* Persons deprived of their liberty by a judicial or administrative decision Persons under psychiatric care Persons admitted to a health or social establishment for purposes other than research Persons of full age subject to a legal protection measure (guardian, curators) Persons not affiliated to a social security scheme or beneficiaries of a similar scheme

Sites / Locations

  • Accueil de jour ARRPACRecruiting

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Patients of program "AVanCer"

Arm Description

Patients included in program "AVanCer"

Outcomes

Primary Outcome Measures

Goal Attainment Scaling (GAS)
The GAS will quantify the achievement of the goals set by the patient. It will be calculated at the end of the programme (planned end or premature exit) on the basis of the objectives set when the patient was included in the programme. The objectives and the different steps to reach them are defined in consultation between the patient, the doctor and the nurse. It is a 5-point scale (-2, -1, 0, 1, 2); -2: level before participation, -1: less than expected; 0: expected goal achieved; +1: a little more than expected; +2: best possible outcome expected.

Secondary Outcome Measures

Quality of life of post-stroke patients measured by SIS (Stroke Impact Scale)
This is a specific quality of life scale for patients post-stroke. The scale contains 64 items measuring 8 different domains (strength, hand functionality, Activities of Daily Living ADL/ Instrumental Activities of Daily Living IADL, mobility, communication, emotion, memory/thinking and social participation) and one item assessing overall recovery out of 100. The items are scored using a Likert scale with 5 response options. The score is reported out of 100 for each dimension (100 = no difficulties, 0= maximum difficulties)
Quality of life of post brain injury patients measured by QOLIBRI (Quality Of LIfe after BRain Injury)
This is a specific quality of life scale for patients post brain injury. The scale contains 37 items measuring 6 different domains (cognitive, affective, functional, relational, physical and emotional). The items are scored using a Likert scale with 5 response options. The score is reported out of 100 (100 = best quality of life, 0 = worst quality of life)
Depression and anxiety measured by HADS (Hospital Anxiety Depression Scale)
This is a specific depression and anxiety scale of 14 items. The scale contains 14 items of which 7 measure anxiety and 7 measure depression. The items are scored from 0 to 3, giving two scores out of 21 for each dimension; a score above 11 indicates an anxious or depressed state.
Autonomy measured by modified Rankin score (mRS)
This is a validated 6-level global assessment scale. The score is between 0 et 6, a higher score is associated to a worse outcome.
Walking assessment by 6 MWT (6 Minutes Walking Test)
This is a functional walking test
Autonomy in health assessed by the PAM-13 (Patient Activation Measure)
This is a test assessing skills, knowledge and knowledge, skills and confidence in managing one's health. The scale contains 13 items scored on a 4-point Likert scale. The total score is reported out of 100 (100 = maximum activation, 0 = no activation)
Adhesion to preventive treatment assessed by the Girerd questionnaire
This is a specific self-questionnaire that assesses compliance in 6 items. Each item can be answered by yes or no. For each item, "Yes" scores 0 and "No" scores 1. A final score of 0 means a good observance, of 1 or 2 means a mild compliance problem, and of 3 or more means a poor compliance.
Quality of life of caregivers measured by SF36 (Short Form Health Survey)
This is a validated scale measuring health-related quality of life. Score is between 0 and 100, A higher score is associated to a better outcome.
Depression and anxiety of caregivers measured by HADS (Hospital Anxiety Depression Scale)
This is a specific depression and anxiety scale of 14 items. The scale contains 14 items of which 7 measure anxiety and 7 measure depression. The items are scored from 0 to 3, giving two scores out of 21 for each dimension; a score above 11 indicates an anxious or depressed state.
Perceived burden of caregivers measured by the Zarit questionnaire
This is a self questionnaire assessing the suffering of caregivers. Score is between 0 and 88. A higher score is associated to a worse outcome.
Reaching the target population evaluated by : 1- The description of the active file : description of socio-demographic characteristics
The indicators are obtained from data collected in the user file. The socio-demographic characteristics collected are: age, gender, family status, professional status, social status
Reaching the target population evaluated by : 2-The description of medical characteristics
The indicators are obtained from data collected in the user file. Medical characteristics are type of stroke, treatment and sequelae
Adoption : 1-Integration in the territory evaluated by the department of residence of patients
This indicator is obtained from data collected in the user file.
Adoption : 2-Link with partners assessed by way of patient referral
This indicator is obtained from data collected in the user file. The type of practioner who referred the patient is collected
Adoption : 3-Perception of the structure by professionals
The perception of the structure will be assessed through semi-structured interviews conducted by the research team. The questions focus on the professional's feelings about their participation in the facility and are 30 minutes long
Adoption : 4-Active patient file : number of inclusions per week
This indicator is obtained from data collected in the user file.
Implementation 1-Number of patients present compared to the number of patients planned per activity
This indicator is obtained from data collected in the user file.
Implementation : 2-Follow-up of programs (number of patients per programs)
The follow-up of programs will be described, for each program, by the number of patients per program over time
Implementation : 3-Deployment of therapeutic workshops : description of workshops
Description of workshops in terms of type of activity , rhythm
Maintenance: 1-Over time at the organisational level by monitoring team meetings
Integration into the medico-social offer in the long term via the partnerships established and maintenance of the activities initiated during the program by the patients measured 6 months after the end of the program
Maintenance : 2-Evaluation of the sustainability of activities since the end of the program
One question will focus on the continuation of activities and the description of these activities
Cost
Average cost to produce all the support provided by the programme by modelling the pathways
Assessment of transferability
Assessment of transferability using the ASTAIRE grid (Analysis of transferability and support for the adaptation of health promotion interventions) : it contains 4 categories of criteria: description of the population (descriptive criteria of the population), environment (environmental factors likely to influence the effects), implementation conditions (elements of implementation of the intervention, particularly with reference to aspects of planning and partnerships) and support for transfer (elements that make it possible to support the transfer of the intervention and contribute in particular to its adaptation to the new context.

Full Information

First Posted
February 7, 2023
Last Updated
August 7, 2023
Sponsor
Hospices Civils de Lyon
search

1. Study Identification

Unique Protocol Identification Number
NCT05795686
Brief Title
Evaluation of the Impact of the AVanCer Program Provided by the ARRPAC Day Center
Acronym
Eval-ARRPAC
Official Title
Evaluation of the Impact of the AVanCer Program Provided by the ARRPAC Day Center
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 20, 2023 (Actual)
Primary Completion Date
July 27, 2024 (Anticipated)
Study Completion Date
January 27, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospices Civils de Lyon

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
In France, more than 150,000 strokes occur each year. Stroke is a major risk factor for dependency, representing the leading cause of acquired non-traumatic disability in adults. Head injuries, which are also very frequent, can leave similar neuropsychiatric sequelae. These events are brutal and their physical, psychological, emotional, social and financial consequences disrupt the lives of patients and their families. Thanks to improved access to thrombolysis and thrombectomy for the management of acute stroke, the prognosis has been profoundly improved. Nevertheless, the increase in post-stroke survival and the evolution of the type of after-effects require the development of support systems dedicated to these post-stroke patients. The same issues are raised for people who have suffered a head injury with similar consequences that require specialised care. Currently, health care is well structured for the acute phase and there is an improvement in the provision of care in specialised rehabilitation services, but the dedicated medico-social provision for people returning home remains insufficient despite the significant needs. The ARRPAC association (Accompaniment, Rehabilitation, Respite after Stroke and Cerebral Palsy) is setting up a new comprehensive medico-social support programme in Lyon (AVanCer programme, opening in June 2022) to improve the autonomy and adaptation capacities of patients and to relieve the social and psycho-affective burden of carers. This experimental day centre, which complements functional rehabilitation and recurrence prevention care, offers adults with brain injury sequelae and their carers therapeutic education programmes, adapted physical activity, social and cognitive remediation and therapeutic workshops, as well as a place for patients and their carers to exchange information and listen. To achieve its ambition, ARRPAC and the AVanCer programme must be integrated into the existing support offer, create partnerships with care structures and evaluate its added value to ensure its sustainability. In case of efficiency and demonstrated benefits for patients, carers and the health system, such a structure could be deployed in other territories. This study evaluates the implementation of the AVanCer programme in terms of its effect on the target audience, participants' experience and implementation according to the REAIM evaluative framework (Reach, Effectiveness, Adoption, Implementation, and Maintenance).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke, Brain Injury, Rehabilitation
Keywords
Stroke, Brain injury, Rehabilitation, Autonomy, Caregivers

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Quantitative approach by monitoring the structure's operating indicators Qualitative approach by semi-structured interviews with professionals of the structure For patients: At inclusion:collection of socio-demographic and medical data,Quality of life (QoL) questionnaires,anxiety and depression,autonomy in health,adherence to treatment At end of the program:QoL questionnaires,anxiety and depression,autonomy,autonomy in health,adherence to treatment,satisfaction,semi-structured interviews 6 months post-program:data on retention and re-hospitalization,QoL questionnaires,anxiety and depression,autonomy in health,adherence to treatment For caregivers: At inclusion:collection of socio-demographic data,QoL questionnaires,anxiety and depression,perceived burden At the end of the program:QoL questionnaires,anxiety and depression,perceived burden,semi-structured interviews 6 months post-program:data about new support,QoL questionnaires,anxiety and depression,perceived burden
Masking
None (Open Label)
Allocation
N/A
Enrollment
162 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Patients of program "AVanCer"
Arm Type
Other
Arm Description
Patients included in program "AVanCer"
Intervention Type
Other
Intervention Name(s)
Evaluation of program "AVanCer"
Intervention Description
Evaluation of program AVanCer with quantitative and qualitative approaches
Primary Outcome Measure Information:
Title
Goal Attainment Scaling (GAS)
Description
The GAS will quantify the achievement of the goals set by the patient. It will be calculated at the end of the programme (planned end or premature exit) on the basis of the objectives set when the patient was included in the programme. The objectives and the different steps to reach them are defined in consultation between the patient, the doctor and the nurse. It is a 5-point scale (-2, -1, 0, 1, 2); -2: level before participation, -1: less than expected; 0: expected goal achieved; +1: a little more than expected; +2: best possible outcome expected.
Time Frame
Inclusion (Day 0) ; End of the program (between Month 2 and Month 4)
Secondary Outcome Measure Information:
Title
Quality of life of post-stroke patients measured by SIS (Stroke Impact Scale)
Description
This is a specific quality of life scale for patients post-stroke. The scale contains 64 items measuring 8 different domains (strength, hand functionality, Activities of Daily Living ADL/ Instrumental Activities of Daily Living IADL, mobility, communication, emotion, memory/thinking and social participation) and one item assessing overall recovery out of 100. The items are scored using a Likert scale with 5 response options. The score is reported out of 100 for each dimension (100 = no difficulties, 0= maximum difficulties)
Time Frame
Inclusion (Day 0) ; End of the program (between Month 2 and Month 4) ; 6 months after the end of the program (between Month 8 and Month 10)
Title
Quality of life of post brain injury patients measured by QOLIBRI (Quality Of LIfe after BRain Injury)
Description
This is a specific quality of life scale for patients post brain injury. The scale contains 37 items measuring 6 different domains (cognitive, affective, functional, relational, physical and emotional). The items are scored using a Likert scale with 5 response options. The score is reported out of 100 (100 = best quality of life, 0 = worst quality of life)
Time Frame
Inclusion (Day 0) ; End of the program (between Month 2 and Month 4) ; 6 months after the end of the program (between Month 8 and Month 10)
Title
Depression and anxiety measured by HADS (Hospital Anxiety Depression Scale)
Description
This is a specific depression and anxiety scale of 14 items. The scale contains 14 items of which 7 measure anxiety and 7 measure depression. The items are scored from 0 to 3, giving two scores out of 21 for each dimension; a score above 11 indicates an anxious or depressed state.
Time Frame
Inclusion (Day 0) ; End of the program (between Month 2 and Month 4) ; 6 months after the end of the program (between Month 8 and Month 10)
Title
Autonomy measured by modified Rankin score (mRS)
Description
This is a validated 6-level global assessment scale. The score is between 0 et 6, a higher score is associated to a worse outcome.
Time Frame
Inclusion (Day 0) ; End of the program (between Month 2 and Month 4)
Title
Walking assessment by 6 MWT (6 Minutes Walking Test)
Description
This is a functional walking test
Time Frame
End of the program (between Month 2 and Month 4)
Title
Autonomy in health assessed by the PAM-13 (Patient Activation Measure)
Description
This is a test assessing skills, knowledge and knowledge, skills and confidence in managing one's health. The scale contains 13 items scored on a 4-point Likert scale. The total score is reported out of 100 (100 = maximum activation, 0 = no activation)
Time Frame
Inclusion (Day 0) ; End of the program (between Month 2 and Month 4) ; 6 months after the end of the program (between Month 8 and Month 10)
Title
Adhesion to preventive treatment assessed by the Girerd questionnaire
Description
This is a specific self-questionnaire that assesses compliance in 6 items. Each item can be answered by yes or no. For each item, "Yes" scores 0 and "No" scores 1. A final score of 0 means a good observance, of 1 or 2 means a mild compliance problem, and of 3 or more means a poor compliance.
Time Frame
Inclusion (Day 0) ; End of the program (between Month 2 and Month 4) ; 6 months after the end of the program (between Month 8 and Month 10)
Title
Quality of life of caregivers measured by SF36 (Short Form Health Survey)
Description
This is a validated scale measuring health-related quality of life. Score is between 0 and 100, A higher score is associated to a better outcome.
Time Frame
Inclusion (Day 0) ; End of the program (between Month 2 and Month 4) ; 6 months after the end of the program (between Month 8 and Month 10)
Title
Depression and anxiety of caregivers measured by HADS (Hospital Anxiety Depression Scale)
Description
This is a specific depression and anxiety scale of 14 items. The scale contains 14 items of which 7 measure anxiety and 7 measure depression. The items are scored from 0 to 3, giving two scores out of 21 for each dimension; a score above 11 indicates an anxious or depressed state.
Time Frame
Inclusion (Day 0) ; End of the program (between Month 2 and Month 4) ; 6 months after the end of the program (between Month 8 and Month 10)
Title
Perceived burden of caregivers measured by the Zarit questionnaire
Description
This is a self questionnaire assessing the suffering of caregivers. Score is between 0 and 88. A higher score is associated to a worse outcome.
Time Frame
Inclusion (Day 0) ; End of the program (between Month 2 and Month 4) ; 6 months after the end of the program (between Month 8 and Month 10)
Title
Reaching the target population evaluated by : 1- The description of the active file : description of socio-demographic characteristics
Description
The indicators are obtained from data collected in the user file. The socio-demographic characteristics collected are: age, gender, family status, professional status, social status
Time Frame
Inclusion (Day 0)
Title
Reaching the target population evaluated by : 2-The description of medical characteristics
Description
The indicators are obtained from data collected in the user file. Medical characteristics are type of stroke, treatment and sequelae
Time Frame
Inclusion (Day 0)
Title
Adoption : 1-Integration in the territory evaluated by the department of residence of patients
Description
This indicator is obtained from data collected in the user file.
Time Frame
Inclusion (Day 0)
Title
Adoption : 2-Link with partners assessed by way of patient referral
Description
This indicator is obtained from data collected in the user file. The type of practioner who referred the patient is collected
Time Frame
Inclusion (Day 0)
Title
Adoption : 3-Perception of the structure by professionals
Description
The perception of the structure will be assessed through semi-structured interviews conducted by the research team. The questions focus on the professional's feelings about their participation in the facility and are 30 minutes long
Time Frame
Through study completion, an average of 22 years
Title
Adoption : 4-Active patient file : number of inclusions per week
Description
This indicator is obtained from data collected in the user file.
Time Frame
Through study completion, an average of 22 years
Title
Implementation 1-Number of patients present compared to the number of patients planned per activity
Description
This indicator is obtained from data collected in the user file.
Time Frame
Through study completion, an average of 22 years
Title
Implementation : 2-Follow-up of programs (number of patients per programs)
Description
The follow-up of programs will be described, for each program, by the number of patients per program over time
Time Frame
Through study completion, an average of 22 years
Title
Implementation : 3-Deployment of therapeutic workshops : description of workshops
Description
Description of workshops in terms of type of activity , rhythm
Time Frame
End of study (Month 22)
Title
Maintenance: 1-Over time at the organisational level by monitoring team meetings
Description
Integration into the medico-social offer in the long term via the partnerships established and maintenance of the activities initiated during the program by the patients measured 6 months after the end of the program
Time Frame
End of the program (between Month 2 and Month 4) ; End of study (Month 22)
Title
Maintenance : 2-Evaluation of the sustainability of activities since the end of the program
Description
One question will focus on the continuation of activities and the description of these activities
Time Frame
6 months after end of program (between Month 8 and Month 10)
Title
Cost
Description
Average cost to produce all the support provided by the programme by modelling the pathways
Time Frame
End of study (Month 22)
Title
Assessment of transferability
Description
Assessment of transferability using the ASTAIRE grid (Analysis of transferability and support for the adaptation of health promotion interventions) : it contains 4 categories of criteria: description of the population (descriptive criteria of the population), environment (environmental factors likely to influence the effects), implementation conditions (elements of implementation of the intervention, particularly with reference to aspects of planning and partnerships) and support for transfer (elements that make it possible to support the transfer of the intervention and contribute in particular to its adaptation to the new context.
Time Frame
End of study (Month 22)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: For patients : Male or female of legal age Patient who has been selected to start the AVanCer program at the ARRPAC center Patient who has agreed to participate in the PATIENT assessment component and has signed the consent form Patient able to speak and understand French both orally and in writing For caregivers : Male or female of legal age Person who has agreed to participate in the CAREGIVING assessment component and has signed the consent form Person able to speak and understand French both orally and in writing Population of the qualitative study : Voluntary patients and caregivers who participated in the quantitative part (follow-up by questionnaires) Partner professionals: a sample of 10 representatives of ARRPAC partners who referred people for support during the first 12 months, from the following structures: public Medicine, Surgery, Obstetric health institution, private Medicine, Surgery, Obstetric health institution, public Follow-up and Rehabilitation Care institution, private Follow-up and Rehabilitation Care institution, medico-social institution, town professionals and user associations. ARRPAC professionals: the 14 ARRPAC professionals involved in the day care centre will be interviewed in a semi-structured manner Exclusion Criteria: Pregnant women, parturient or breastfeeding mothers* Persons deprived of their liberty by a judicial or administrative decision Persons under psychiatric care Persons admitted to a health or social establishment for purposes other than research Persons of full age subject to a legal protection measure (guardian, curators) Persons not affiliated to a social security scheme or beneficiaries of a similar scheme
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Julie Haesebaert, MD
Phone
06-51-42-97-43
Ext
+33
Email
julie.haesebaert01@chu-lyon.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Anne Termoz
Phone
04-27-85-63-00
Ext
+33
Email
anne.termoz@chu-lyon.fr
Facility Information:
Facility Name
Accueil de jour ARRPAC
City
Bron
ZIP/Postal Code
69500
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Stéphanie Fanara
Phone
04-82-90-54-83
Ext
+33
Email
s.fanara@gcsms-arrpac.fr

12. IPD Sharing Statement

Learn more about this trial

Evaluation of the Impact of the AVanCer Program Provided by the ARRPAC Day Center

We'll reach out to this number within 24 hrs